|
Volumn 29, Issue 3, 2006, Pages 183-185
|
The unknown impacts of combinations of large numbers of drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
IBUPROFEN;
CHRONIC DISEASE;
DISEASE EXACERBATION;
DRUG ADMINISTRATION ROUTE;
DRUG ANTAGONISM;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG INDUCED DISEASE;
DRUG LEGISLATION;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG SAFETY;
EDITORIAL;
FOOD DRUG INTERACTION;
HERB DRUG INTERACTION;
HUMAN;
MULTIPLE DRUG DOSE;
PATIENT COMPLIANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
AGED;
CHRONIC DISEASE;
CLINICAL TRIALS;
CLINICAL TRIALS AS TOPIC;
DRUG COMBINATIONS;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
HUMANS;
MODELS, STATISTICAL;
PHARMACEUTICAL PREPARATIONS;
PHARMACOEPIDEMIOLOGY;
RISK;
|
EID: 33644835423
PISSN: 01145916
EISSN: 01145916
Source Type: Journal
DOI: 10.2165/00002018-200629030-00001 Document Type: Editorial |
Times cited : (5)
|
References (11)
|